Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T
Jeanne du Fay de Lavallaz, Alexandra Prepoudis, Maria Janina Wendebourg, et al.
Circulation (2022) Vol. 145, Iss. 24, pp. 1764-1779
Open Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

Fatal outcomes following onasemnogene abeparvovec in advanced-stage spinal muscular atrophy
Peerada Pongsakornkullachart, Pimchanok Kulsirichawaroj, Ratcharin Kongkasuwan, et al.
Gene Therapy (2025)
Open Access
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection
Anda Bularga, Ellen Oskoui, Takeshi Fujisawa, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 8, pp. 1015-1019
Open Access | Times Cited: 16
Role of Antitroponin Antibodies and Macrotroponin in the Clinical Interpretation of Cardiac Troponin
Erwan Salaün, Samuel Bernard Drory, Marc‐André Coté, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 3
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge?
Valentina A. Rossi, Joanna Gawinecka, Florentia Dimitriou, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 4, pp. 2680-2685
Open Access | Times Cited: 9
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
Alexi Vasbinder, Anis Ismail, Joe-Élie Salem, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 9, pp. 959-967
Closed Access | Times Cited: 8
A multidisciplinary approach to the diagnosis of antisynthetase syndrome
Matthew Wells, Sughra Alawi, Kyaing Yi Mon Thin, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Cardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral Vision
Christopher R. deFilippi, Ana Barac
Circulation (2023) Vol. 148, Iss. 15, pp. 1135-1137
Closed Access | Times Cited: 7
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV
Christopher R. deFilippi, Sara McCallum, Markella V. Zanni, et al.
JACC Advances (2024) Vol. 3, Iss. 9, pp. 101206-101206
Open Access | Times Cited: 2
Four high sensitivity troponin assays and mortality in US adults with cardiovascular disease: The national health and nutrition examination survey, 1999–2004
John W. McEvoy, Dan Wang, Olive Tang, et al.
American Journal of Preventive Cardiology (2024) Vol. 17, pp. 100631-100631
Open Access | Times Cited: 2
Troponin T is elevated in a relevant proportion of patients with 5q-associated spinal muscular atrophy
Hanna Sophie Lapp, Maren Freigang, Johannes Friese, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis
Teresa Koch, Rachel Fabian, Leonie Weinhold, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 8, pp. 2063-2072
Open Access | Times Cited: 2
Interpretation of elevated baseline concentrations and serial changes of high‐sensitivity cardiac troponin T in confirmed muscular dystrophies
Mustafa Yıldırım, Christoph Reich, Christian Salbach, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3732-3741
Open Access | Times Cited: 2
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era
Allison L Gradone, T. Vincent, Alexi Vasbinder, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access | Times Cited: 2
Diagnostic and prognostic value of the sex-specific 99th percentile of four high-sensitivity cardiac troponin assays in patients with suspected myocardial infarction
Jonas Lehmacher, Nils A. Sörensen, Raphael Twerenbold, et al.
European Heart Journal Acute Cardiovascular Care (2023) Vol. 13, Iss. 1, pp. 3-12
Closed Access | Times Cited: 6
The clinical importance of high-sensitivity cardiac troponin measurements for risk prediction in non-cardiac surgery
Sjur H. Tveit, Peder L. Myhre, Torbjørn Omland
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 6, pp. 535-544
Open Access | Times Cited: 5
LncRNA-encoded peptides: unveiling their significance in cardiovascular physiology and pathology—current research insights
Li Zhang, Mi Tang, Haoyang Diao, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 12, pp. 2165-2178
Closed Access | Times Cited: 4
Resolved Myositis, Normal Creatine Kinase, and Peaking Cardiac Troponin T
Farida Almarzooqi, Amir Karin, André Mattman, et al.
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 4, pp. 848-853
Closed Access | Times Cited: 1
Individual and Joint Associations of High‐Sensitivity Troponin I and High‐Sensitivity Troponin T with Cardiac Phenotypes and Outcomes in the General Population: An Analysis From the Dallas Heart Study
Rebecca Vigen, Colby Ayers, Jarett D. Berry, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 13
Open Access | Times Cited: 1
Elevated Troponin T in Immune-Checkpoint Inhibitor Myositis
Carissa Beaulieu, Kai Yi Wu, Anna K. Füzéry, et al.
JACC Case Reports (2024) Vol. 29, Iss. 16, pp. 102462-102462
Open Access | Times Cited: 1
Cardiac troponins: Mechanisms of release and role in healthy and diseased subjects
Rosetta Ragusa, Silvia Masotti, Veronica Musetti, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 351-364
Closed Access | Times Cited: 7
Troponin T in spinal and bulbar muscular atrophy (SBMA)
Giulia Musso, Lorenzo Blasi, Monica Mion, et al.
Journal of the Neurological Sciences (2023) Vol. 456, pp. 122816-122816
Closed Access | Times Cited: 3
The role of circulating biomarkers in predicting the 30-day mortality of immune checkpoint inhibitors-related myocarditis: a retrospective cohort study
Yuansong Zhuang, Quanxu An, Fuhang Wang, et al.
Internal and Emergency Medicine (2023) Vol. 19, Iss. 2, pp. 377-389
Closed Access | Times Cited: 3
High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy
Jessika Johannsen, Deike Weiss, Joenna Driemeyer, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 2
At the Crossroad Between Skeletal and Cardiac Muscle Cells
Christopher R. deFilippi, Abdulla A. Damluji
Circulation (2022) Vol. 145, Iss. 24, pp. 1780-1783
Open Access | Times Cited: 3
Cardiac Troponin T is a Serum Biomarker of Respiratory Dysfunction in Amyotrophic Lateral Sclerosis
Teresa Koch, Rachel Fabian, Leonie Weinhold, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top